Document is current
Any future updates will be listed below
-
Authors
Nagasaka, Misako https://orcid.org/0000-0001-5308-615X
Uddin, Mohammed Hafiz
Al-Hallak, Mohammed Najeeb
Rahman, Sarah
Balasubramanian, Suresh
Sukari, Ammar
Azmi, Asfar S.
- License Information
-
More Information
Article History
Received: 1 November 2020
Accepted: 13 May 2021
First Online: 1 June 2021
Declarations
:
: NA
: NA
: The authors have not received any funding for this study and declare no direct conflict of interest. Dr. Nagasaka serves on the advisory board for AstraZeneca, Caris Life Sciences, Daiichi-Sankyo, Takeda, Novartis, EMD Serono and has received study funding from Tempus. Dr. Sukari serves on the advisory board for Merck and Eisai. He has received study funding from Eisai. Dr. Azmi received funding from Karyopharm, EISAI, Janssen and serves as a consultant for GLG and Guidepoint. All other authors have no potential conflict of interest to declare.
